Global Patent Index - EP 4182026 A1

EP 4182026 A1 20230524 - CANNABIDIOL (CBD) BASED COMPOSITION AND METHOD FOR TREATING PAIN

Title (en)

CANNABIDIOL (CBD) BASED COMPOSITION AND METHOD FOR TREATING PAIN

Title (de)

ZUSAMMENSETZUNG AUF DER BASIS VON CANNABIDIOL (CBD) UND VERFAHREN ZUR BEHANDLUNG VON SCHMERZEN

Title (fr)

COMPOSITION À BASE DE CANNABIDIOL (CBD) ET MÉTHODE DE TRAITEMENT DE LA DOULEUR

Publication

EP 4182026 A1 20230524 (EN)

Application

EP 21843338 A 20210719

Priority

  • US 202063053558 P 20200717
  • US 2021042243 W 20210719

Abstract (en)

[origin: WO2022016160A1] Compositions and methods for relieving acute pain, muscular pain, neuropathic pain, and the chronic pain by administering an effective amount of an analgesic composition (preferably formulated as a cream, a gel, a lotion, an ointment, or a salve) including at least: (i) one or more cannabis compounds; (ii) histamine dihydrochloride, salicylate, camphor, menthol, primrose oil, capsaicin, or any of the combination thereof; and optionally, four or more compounds acting as at least antimicrobial preservative(s), antioxidant(s), dispersant(s), emollient(s), emulsifier(s), humectant(s), lubricant(s), penetration enhancer(s), skin conditioner(s), skin protectant(s), thickener(s), or any of the combination thereof to an affected area of a subject in need of pain relief. In a preferred embodiment, the optional third category contributes six or more compounds. Relief of acute and chronic pain without significant deleterious side effects is provided thereby.

IPC 8 full level

A61P 29/00 (2006.01); A61K 31/352 (2006.01); A61K 31/4172 (2006.01); A61K 36/534 (2006.01); A61K 36/67 (2006.01); A61K 36/886 (2006.01)

CPC (source: EP US)

A61K 9/0014 (2013.01 - EP); A61K 9/06 (2013.01 - US); A61K 9/7023 (2013.01 - US); A61K 31/05 (2013.01 - EP US); A61K 31/125 (2013.01 - EP US); A61K 31/165 (2013.01 - EP US); A61K 31/352 (2013.01 - EP); A61K 31/355 (2013.01 - EP US); A61K 31/375 (2013.01 - EP US); A61K 31/417 (2013.01 - EP US); A61K 31/60 (2013.01 - EP US); A61K 31/658 (2023.05 - US); A61K 36/185 (2013.01 - EP); A61K 36/67 (2013.01 - EP US); A61K 36/886 (2013.01 - EP US); A61K 47/10 (2013.01 - US); A61K 47/18 (2013.01 - US); A61K 47/32 (2013.01 - US); A61P 23/02 (2018.01 - US); A61P 29/00 (2018.01 - EP); A61K 47/10 (2013.01 - EP); A61K 47/14 (2013.01 - EP); A61K 47/18 (2013.01 - EP); A61K 47/24 (2013.01 - EP); A61K 47/32 (2013.01 - EP)

C-Set (source: EP)

  1. A61K 36/185 + A61K 2300/00
  2. A61K 36/886 + A61K 2300/00
  3. A61K 36/67 + A61K 2300/00
  4. A61K 31/05 + A61K 2300/00
  5. A61K 31/352 + A61K 2300/00
  6. A61K 31/165 + A61K 2300/00
  7. A61K 31/355 + A61K 2300/00
  8. A61K 31/375 + A61K 2300/00
  9. A61K 31/125 + A61K 2300/00
  10. A61K 31/60 + A61K 2300/00
  11. A61K 31/417 + A61K 2300/00

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2022016160 A1 20220120; CA 3185514 A1 20220120; EP 4182026 A1 20230524; EP 4182026 A4 20241002; US 2024009207 A1 20240111

DOCDB simple family (application)

US 2021042243 W 20210719; CA 3185514 A 20210719; EP 21843338 A 20210719; US 202118005819 A 20210719